CCL25 and neoplasm: Since the observed immune-modulatory effect was not based on CCR9-mediated tumor cell intrinsic signaling, nor mediated through soluble factors including CCL25, our data favor the assumption of a direct interaction between CCR9 on tumor cells and a yet unknown immune-modulatory ligand on T cells.